Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

SHE:300049 Revenue

Inner Mongolia Furui Medical Science had revenue of 394.65M CNY in the quarter ending June 30, 2026, with 3.04% growth. This brings the company's total for the last twelve months to 1.64B, up 15.28% year-over-year. In the year 2025, Inner Mongolia Furui Medical Science had annual revenue of 1.60B with 18.26% growth. That makes Inner Mongolia Furui Medical Science the 15,961st largest company in the world by revenue and 2,873rd in China.

• Revenue (ttm): 1.64B
• Revenue Growth: +15.28%
• P/S Ratio: 6.20
• Revenue / Employee: 1.73M
• Employees: 946
• Market Cap: 9.97B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Equipment and Technology Division 1.13B 71.0%
• Pharmaceuticals and Services Division 461.99M 29.0%

By Geography

Chart

• Overseas 1.06B 66.7%
• China 531.76M 33.3%

Fiscal year ended Dec 31, 2025 See the full SHE:300049 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.60B	246.37M	18.26%
Dec 31, 2024	1.35B	195.28M	16.93%
Dec 31, 2023	1.15B	144.97M	14.37%
Jan 1, 2023	1.01B	110.28M	12.27%
Jan 1, 2022	898.48M	90.95M	11.26%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error